The new regulation is not just an opportunity for medical device manufacturers to identify organizational inefficiencies and streamline processes, but rather a chance for them to increase transparency, accountability and even brand confidence. Those manufacturers that demonstrate a commitment to compliance and give their customers reassurance will find their products are better received as the desire for greater transparency increases.
About the author: Bob Tilling is the VP of global sales at Kallik.Back to HCB News
